ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
부갑상선 호르몬 시장 규모는 최근 급성장하고 있습니다. 2025년 25억 1,000만 달러에서 2026년에는 28억 달러에 이르고, CAGR 11.5%의 성장이 전망되고 있습니다. 지난 수년간의 성장 요인으로는 재조합 부갑상선 호르몬 공급 제한, 환자들의 낮은 질환 인식, 기존 비타민D 요법에 대한 의존도, 병원 및 클리닉 인프라 확충, 수술 후 부갑상선 합병증 증가 등을 꼽을 수 있습니다.
부갑상선 호르몬 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 44억 달러에 이르고, CAGR은 11.9%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 첨단 부갑상선 호르몬 유사체 개발, 개인 맞춤형 의료 접근법 확산, 병원 및 전문 클리닉 확대, 디지털 환자 모니터링 도구의 통합, 저칼슘혈증 및 부갑상선 기능 저하증에 대한 정부 및 의료기관의 노력 강화 등이 꼽힙니다. 강화 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 저칼슘혈증 및 부갑상선 기능 저하증 발병률 증가, 재조합 부갑상선 호르몬 요법 사용 증가, 개인 맞춤형 치료를 위한 부갑상선 호르몬 유사체의 성장, 병원 및 클리닉 기반 부갑상선 치료 프로그램 확대, 수술 후 관리 및 비타민D 보충에 대한 관심 증가 등이 있습니다. 등을 꼽을 수 있습니다.
고령화 인구 증가는 향후 몇 년 동안 부갑상선 호르몬 시장의 성장을 견인할 것으로 예측됩니다. 고령화 인구는 일반적으로 65세 이상의 연령층으로, 노화에 따른 건강 문제에 직면하여 전문적인 건강관리와 지원이 필요한 계층입니다. 이러한 인구통계학적 추세는 주로 평균수명의 연장, 의료수준의 향상, 출산율 감소 등의 요인이 복합적으로 작용하여 전 세계적으로 고령자 비율이 증가하고 있습니다. 부갑상선 호르몬은 칼슘 균형과 뼈 대사를 조절하여 노인에게 중요한 역할을 하며, 노인에게 많이 나타나는 골다공증과 골절의 위험 감소에 기여합니다. 예를 들어, 미국 비영리단체인 인구문제연구소의 예측에 따르면, 2024년 1월 기준 65세 이상 미국인의 수는 2022년 5,800만 명에서 2050년 8,200만 명으로 47% 증가할 것으로 예상하고 있습니다. 또한, 같은 기간 동안 이 연령대가 전체 인구에서 차지하는 비중은 17%에서 23%로 확대될 것으로 예측됩니다. 그 결과, 고령화 인구 증가가 부갑상선 호르몬 시장의 성장에 크게 기여하고 있습니다.
부갑상선 호르몬 시장의 주요 기업들은 부갑상선 호르몬(PTH) 프로드럭을 포함한 부갑상선 기반 치료제의 바이오시밀러 개발에 집중하고 있으며, 치료의 대중성과 효능을 향상시키기 위해 노력하고 있습니다. 부갑상선 호르몬 프로드러그는 투여 후 활성형 PTH로 전환되는 불활성 물질로, 지속 방출과 안정적인 치료 효과로 칼슘 조절과 뼈 건강 유지에 도움을 줍니다. 예를 들어, 2024년 8월 덴마크 바이오 제약사 Ascendis Pharma는 미국 식품의약국(FDA)이 성인 부갑상선 기능저하증 치료제로 YORVIPATH(팔로페그테리파라타이드)를 최초로 승인했다고 발표했습니다. 1일 1회 투여하는 이 프로드러그는 지속적인 PTH 노출을 제공하며, 미국에서 약 70,000-90,000명의 환자들에게 혜택을 제공하도록 설계되었습니다. 제조업체인 Ascendis Pharma는 Ascendis Signature Access Program(A.S.A.P.)을 통해 환자 지원을 제공하고 있으며, 고칼슘혈증 및 저칼슘혈증 위험 관리를 위해 환자들은 주기적으로 혈청 칼슘 농도를 정기적으로 혈청 칼슘 농도를 모니터링해야 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Parathyroid hormone is a substance secreted by the parathyroid gland that helps regulate the storage and use of calcium in the body. Elevated levels of parathyroid hormone can lead to increased blood calcium levels and may indicate the presence of a disease. It is also referred to as PTH, parathyrin, and parathormone.
The primary product types in the parathyroid hormone category include recombinant parathyroid hormone and parathyroid hormone analogs. Recombinant parathyroid hormone, which imitates the action of natural parathyroid hormone, is utilized in the treatment of osteoporosis. The various conditions addressed include hypocalcemia and hypoparathyroidism, and these products are used across multiple settings such as hospitals, clinics, and others.
Tariffs have impacted the parathyroid hormone market by increasing the cost of imported recombinant hormones, analogues, and related medical devices. Hospital and clinic segments in regions like North America and Europe, which depend on imports, are most affected. This has led to higher treatment costs and supply chain challenges. However, tariffs have also promoted local manufacturing, encouraged innovation in hormone therapies, and supported the development of cost-optimized solutions.
The parathyroid hormone market research report is one of a series of new reports from The Business Research Company that provides parathyroid hormone market statistics, including parathyroid hormone industry global market size, regional shares, competitors with a parathyroid hormone market share, detailed parathyroid hormone market segments, market trends and opportunities, and any further data you may need to thrive in the parathyroid hormone industry. This parathyroid hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The parathyroid hormone market size has grown rapidly in recent years. It will grow from $2.51 billion in 2025 to $2.8 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to limited availability of recombinant parathyroid hormone, low disease awareness among patients, reliance on conventional vitamin d therapy, growing hospital and clinic infrastructure, increasing post-surgical parathyroid complications.
The parathyroid hormone market size is expected to see rapid growth in the next few years. It will grow to $4.4 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to development of advanced parathyroid hormone analogues, rising adoption of personalized medicine approaches, expansion of hospital and specialty clinics, integration of digital patient monitoring tools, increasing government and healthcare initiatives for hypocalcemia and hypoparathyroidism. Major trends in the forecast period include rising incidence of hypocalcemia and hypoparathyroidism, increasing use of recombinant parathyroid hormone therapies, growth in parathyroid hormone analogues for personalized treatment, expansion of hospital and clinic-based parathyroid care programs, focus on post-surgical management and vitamin d supplementation.
The growing geriatric population is expected to drive the expansion of the parathyroid hormone market in the coming years. The geriatric population includes older adults, generally aged 65 years and above, who often face age-related health conditions and require specialized medical care and support. This demographic trend is largely the result of longer life expectancy, improvements in healthcare, and declining birth rates, which together have increased the proportion of elderly individuals worldwide. Parathyroid hormone plays an important role for older adults by regulating calcium balance and bone metabolism, thereby helping reduce the risk of osteoporosis and fractures, conditions commonly seen in the aging population. For example, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization, the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Additionally, this age group's share of the total population is expected to grow from 17% to 23% over the same period. As a result, the expanding geriatric population is contributing significantly to the growth of the parathyroid hormone market.
Leading companies in the parathyroid hormone market are concentrating on the development of biosimilars of parathyroid-based therapies, including prodrugs of parathyroid hormone (PTH), to improve treatment availability and effectiveness. A parathyroid hormone prodrug is an inactive substance that converts into active PTH after administration, allowing for sustained release and consistent therapeutic effects to support calcium regulation and bone health. For instance, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, announced that the Food & Drug Administration (FDA) had approved YORVIPATH (palopegteriparatide) as the first and only treatment for hypoparathyroidism in adults. This once-daily prodrug provides continuous PTH exposure and is designed to benefit approximately 70,000 to 90,000 patients in the United States. The manufacturer, Ascendis Pharma, also offers patient support through its Ascendis Signature Access Program (A.S.A.P.), although patients are required to regularly monitor serum calcium levels to manage the risk of hypercalcemia or hypocalcemia.
In November 2023, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, entered into a strategic partnership with Teijin Limited in Japan to support the development and commercialization of innovative therapies. This collaboration is intended to broaden access to Ascendis Pharma's pipeline products, improve patient care in Japan, and promote innovation and growth within the rare disease and endocrine therapeutics market. Teijin Limited is a Japan-based healthcare and pharmaceutical company dedicated to providing advanced therapies and solutions to address unmet medical needs.
Major companies operating in the parathyroid hormone market are Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited
North America was the largest region in the parathyroid hormone market in 2025. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the parathyroid hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The parathyroid hormone market consists of sales of parathormone and calcitonin. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Parathyroid Hormone Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses parathyroid hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for parathyroid hormone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The parathyroid hormone market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Disease Type: Hypocalcemia; Hypoparathyroidism
2) By Product Type: Recombinant Parathyroid Hormone; Parathyroid Hormone Analogues
3) By End-User: Hospitals; Clinics; Other End-Users
Subsegments:
1) By Hypocalcemia: Pseudohypoparathyroidism; Vitamin D Deficiency
2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism; Idiopathic Hypoparathyroidism
Companies Mentioned: Pfizer Inc.; Eli Lilly and Company; Radius Health Inc.; Ascendis Pharma; Entera Bio Ltd.; Extend Biosciences Inc.; Gedeon Richter Plc.; Abbott Laboratories; Amgen Inc.; Merck & Co. Inc.; Novartis AG; F. Hoffmann-La Roche AG; Teva Pharmaceutical Industries Ltd.; Alcon Laboratories Inc.; Bayer Healthcare; AstraZeneca PLC; Biocon; Dr. Reddy's Laboratories; Glenmark Pharmaceuticals; Jubilant Life Sciences; Lupin Limited; Sun Pharmaceutical Industries; Torrent Pharmaceuticals; Wockhardt; Cipla Limited
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Incidence Of Hypocalcemia And Hypoparathyroidism
4.2.2 Increasing Use Of Recombinant Parathyroid Hormone Therapies
4.2.3 Growth In Parathyroid Hormone Analogues For Personalized Treatment
4.2.4 Expansion Of Hospital And Clinic-Based Parathyroid Care Programs
4.2.5 Focus On Post-Surgical Management And Vitamin D Supplementation
5. Parathyroid Hormone Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Specialty Endocrinology Centers
5.4 Diagnostic Laboratories
5.5 Home Healthcare Providers
6. Parathyroid Hormone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Parathyroid Hormone Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Parathyroid Hormone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Parathyroid Hormone Market Size, Comparisons And Growth Rate Analysis
7.3. Global Parathyroid Hormone Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Parathyroid Hormone Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Parathyroid Hormone Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Parathyroid Hormone Market Segmentation
9.1. Global Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hypocalcemia, Hypoparathyroidism
9.2. Global Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.3. Global Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Other End-Users
9.4. Global Parathyroid Hormone Market, Sub-Segmentation Of Hypocalcemia, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pseudohypoparathyroidism, Vitamin D Deficiency
9.5. Global Parathyroid Hormone Market, Sub-Segmentation Of Hypoparathyroidism, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Parathyroid Hormone Market
12.1. China Parathyroid Hormone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Parathyroid Hormone Market
13.1. India Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Parathyroid Hormone Market
14.1. Japan Parathyroid Hormone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Parathyroid Hormone Market
15.1. Australia Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Parathyroid Hormone Market
16.1. Indonesia Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Parathyroid Hormone Market
17.1. South Korea Parathyroid Hormone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Parathyroid Hormone Market
18.1. Taiwan Parathyroid Hormone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Parathyroid Hormone Market
19.1. South East Asia Parathyroid Hormone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Parathyroid Hormone Market
20.1. Western Europe Parathyroid Hormone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Parathyroid Hormone Market
21.1. UK Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Parathyroid Hormone Market
22.1. Germany Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Parathyroid Hormone Market
23.1. France Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Parathyroid Hormone Market
24.1. Italy Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Parathyroid Hormone Market
25.1. Spain Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Parathyroid Hormone Market
26.1. Eastern Europe Parathyroid Hormone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Parathyroid Hormone Market
27.1. Russia Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Parathyroid Hormone Market
28.1. North America Parathyroid Hormone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Parathyroid Hormone Market
29.1. USA Parathyroid Hormone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Parathyroid Hormone Market
30.1. Canada Parathyroid Hormone Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Parathyroid Hormone Market
31.1. South America Parathyroid Hormone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Parathyroid Hormone Market
32.1. Brazil Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Parathyroid Hormone Market
33.1. Middle East Parathyroid Hormone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Parathyroid Hormone Market
34.1. Africa Parathyroid Hormone Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Parathyroid Hormone Market Regulatory and Investment Landscape
36. Parathyroid Hormone Market Competitive Landscape And Company Profiles
36.1. Parathyroid Hormone Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Parathyroid Hormone Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Parathyroid Hormone Market Company Profiles
36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Radius Health Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Ascendis Pharma Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Entera Bio Ltd. Overview, Products and Services, Strategy and Financial Analysis
37. Parathyroid Hormone Market Other Major And Innovative Companies
